We noticed JavaScript is turned off in your browser settings. For a better viewing experience, enable JavaScript. If you're unsure of how to do this, click here to download a new browser.

FOR PREVIEW ONLY (Print)

Allen S. Ho, MD

Director, Head and Neck Cancer Program

Co-Director, Thyroid Cancer Program

8635 W. Third St.
Suite 590W
Los Angeles, CA 90048

Phone:

310-423-1220

Fax:

310-423-1230

Parking Instructions:

Parking entrance located on George Burns Rd. between 3rd St. and Alden Dr.

Allen S. Ho, MD

Director, Head and Neck Cancer Program

Co-Director, Thyroid Cancer Program

  • Otolaryngology

HPV (Human Papillomavirus)

Head and Neck Cancers

Head and Neck Surgery / Surgeries

Head and Neck Tumors

Laryngeal Cancer

Oral Surgery

Oropharyngeal Cancers (Tonsil, Tongue Base)

Parathyroid Surgery / Surgeries

Salivary Gland Disorders

Salivary Gland Tumors

Sinus Cancers

Sinus Surgery / Surgeries

Skin Cancer Surgery / Surgeries

Skull Base Surgery / Surgeries

Thyroid Cancers

Thyroid Surgery / Surgeries

Dr. Ho's research interests lie in head and neck cancer genomics, HPV+ oropharyngeal cancer pathogenesis, transoral robotic surgery, and thyroid cancer active surveillance.

  • Undergraduate: Harvard University, 2000
  • Fellowship: National Institutes of Health, 2004
  • Medical School: University of California, Los Angeles David Geffen School of Medicine, 2006
  • Residency: Stanford University School of Medicine- Otolaryngology- Head & Neck Surgery, 2011
  • Fellowship: Memorial Sloan-Kettering Cancer Center- Head & Neck Surgical Oncology, 2013
  • Super Doctors Rising Stars, 2015
  • Recipient- AHNS Young Investigator Award
  • Recipient- NIH Ruth Kirschstein National Research Service Award
  • Recipient- Adenoid Cystic Carcinoma Foundation Grant
  • Recipient- HHMI-NIH Continuing Support Scholarship
  • Member- American Association of Otolaryngology, Head and Neck Surgery
  • Member- American Head and Neck Society
  • Member- American Thyroid Association
  • Member- AAOHNS Head and Neck Surgery and Oncology Committee

Show moreShow less

Click here for a list of peer-reviewed publications.

  • Marti JL, Avadhani V, Donatelli LA, Niyogi S, Wang B, Wong RJ, Shaha AR, Ghossein RA, Lin O, Morris LG, Ho AS. Wide inter-institutional variation in performance of a molecular classifier for indeterminate thyroid nodules. Annals of Surgical Oncology. 2015 Apr 11.
  • Ho AS, Davies L, Nixon IJ, et al. Increasing diagnosis of subclinical thyroid cancers leads to spurious improvements in survival rates. Cancer. 2015 Feb 24.
  • Ho AS, Sarti EE, Jain KS, et al. Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS). Thyroid. 2014 May;24(5):832-9.
  • Ho AS, Kannan K, Roy DM, et al. The mutational landscape of adenoid cystic carcinoma. Nature Genetics. 2013 Jul;45(7):791-8.
  • Ho AS, Kraus DH, Ganly I, et al. Decision making in the management of recurrent head and neck cancer. Head Neck. 2014 Jan;36(1):144-51.
  • Ho AS, Tsao GJ, Chen FW, et al. Impact of PET/CT surveillance at 12 and 24 months for detecting head and neck cancer recurrence. Cancer. 2013 Apr 1;119(7):1349-56.

Show moreShow less

English / Chinese (Mandarin)

Make an Appointment

Call

1-800-CEDARS-1

(1-800-233-2771)

Available 24 Hours A Day

or